Patient Access & Support

Patient Access & Support is the operating layer that turns a specialty prescription into a filled, paid-for, and adherent therapy. For a US launch, this is not optional infrastructure: without hub services, copay and affordability support, reimbursement help, and a specialty pharmacy path, friction between prescriber, payer, dispenser, and patient can strand a script before it ships.

The economics are direct. Specialty brands live on start rate, time to fill, and persistence. Prior authorization delays and high out-of-pocket cost create abandonment, while weak hub-to-pharmacy data hides where patients are falling out. The access stack protects speed-to-therapy, gross-to-net assumptions, and the patient-support experience the launch forecast depends on.

The market splits into a few clear lanes. Hub platforms such as AssistRx, ConnectiveRx, Lash Group under Eversana, and Mercalis run enrollment, benefit investigation, prior authorization, case management, and adherence. Specialty pharmacies range from PBM-owned dispensers such as Accredo, CVS Specialty, and Optum to independents with depth in oncology, rare disease, and limited-distribution models. Copay and affordability vendors administer commercial copay support, foundation referrals, and bridge programs, while field reimbursement teams handle payer-by-payer access barriers on the ground.

The buyer challenge is that this market is structurally conflicted. PBM-owned specialty pharmacies sit inside parent companies that also control formularies, networks, and payer economics, while accumulators, maximizers, and alternative funding programs can absorb manufacturer assistance without lowering a patient's real cost. Vendor diligence has to separate genuine patient access from channel margin capture.

Selection starts with two decisions: integrated hub versus best-of-breed stack, and technology-led workflow versus services-heavy support. The strongest programs integrate hub, specialty pharmacy, copay, and field reimbursement data so the manufacturer can see speed-to-therapy, prior-authorization turnaround, abandonment, adherence, persistence, and patient-assistance compliance in one operating view.